Mastek Ltd (MASTEK) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Mastek Ltd. reported strong overall performance in FY25, with revenue from operations growing by 13.1% and net profit increasing by 20.9%.
- Cash and cash equivalents increased to 622 crores from 473 crores in FY24.
- UK and Europe business showed exceptional performance, with Q4 revenue growing by 17.2% YoY and 9.4% QoQ.
- Healthcare sector in the UK achieved remarkable growth, exceeding 100% YoY.
- The company declared a final dividend of 16, resulting in a cumulative dividend of 480% for the year.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.